Vivek Subbiah/X
May 30, 2025, 15:13
Vivek Subbiah: Exhilarating Discussions with Erika Hamilton at the ASCO 2025 Annual Meeting
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute (USA), shared a post on X:
“Calm before the storm? Exhilarating discussions with the Scientific Chair of ASCO25 Erika Hamilton as the pre-view meeting kicks off in the music city before we head off to Chicago ! Momentum is building. Let’s go ASCO25!”
More posts featuring ASCO 2025.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 23, 2025, 11:18
Jun 23, 2025, 10:55
Jun 23, 2025, 09:19
Jun 23, 2025, 08:55
Jun 23, 2025, 08:55